A Study of SI-6603 in Patients With Lumbar Disc Herniation

PHASE3CompletedINTERVENTIONAL
Enrollment

1,011

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Intervertebral Disc DiseaseLumbar Disc Disease
Interventions
DRUG

Condoliase

1.25 U, intradiscal injection, one time

Trial Locations (48)

Unknown

Mobile

Phoenix

Gold River

Laguna Hills

Los Gatos

Riverside

Temecula

Greenwood Village

Clermont

Hialeah

Jacksonville

Miami

Miami Gardens

Naples

Pinellas Park

Sarasota

South Miami

St. Petersburg

Winter Park

Marietta

Newnan

Bloomington

Carmel

Shreveport

City of Saint Peters

Hartsdale

Eugene

Charleston

Plano

Sandy City

Eichstätt

Frankfurt am Main

Cologne

Göppingen

Berlin

Hamburg

Brasov

Bucharest

Sibiu

Cadiz

Palma de Mallorca

Badalona

Terrassa

Valladolid

Alcorcón

Barcelona

Ourense

Valencia

All Listed Sponsors
lead

Seikagaku Corporation

INDUSTRY

NCT02421601 - A Study of SI-6603 in Patients With Lumbar Disc Herniation | Biotech Hunter | Biotech Hunter